The global market for AI in Respiratory Diseases was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for AI in Respiratory Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for AI in Respiratory Diseases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for AI in Respiratory Diseases in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of AI in Respiratory Diseases include ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, THIRONA, DeepMind Health, Verily, VIDA Diagnostics Inc, Icometrix, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for AI in Respiratory Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI in Respiratory Diseases.

The AI in Respiratory Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI in Respiratory Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the AI in Respiratory Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of AI in Respiratory Diseases Market Report

Report Metric	Details
Report Name	AI in Respiratory Diseases Market
Segment by Type	Pulmonary Infection MRI CT Scan
Segment by Application	Hospital Diagnostic Centers Ambulatory Surgical Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, THIRONA, DeepMind Health, Verily, VIDA Diagnostics Inc, Icometrix, Infervision, PneumoWave, Respiray, Dectrocel Healthcare, Zynnon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI in Respiratory Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI in Respiratory Diseases Market report?

Ans: The main players in the AI in Respiratory Diseases Market are ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, THIRONA, DeepMind Health, Verily, VIDA Diagnostics Inc, Icometrix, Infervision, PneumoWave, Respiray, Dectrocel Healthcare, Zynnon

What are the Application segmentation covered in the AI in Respiratory Diseases Market report?

Ans: The Applications covered in the AI in Respiratory Diseases Market report are Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the AI in Respiratory Diseases Market report?

Ans: The Types covered in the AI in Respiratory Diseases Market report are Pulmonary Infection, MRI, CT Scan

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI in Respiratory Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Pulmonary Infection

1.2.3 MRI

1.2.4 CT Scan

1.3 Market by Application

1.3.1 Global AI in Respiratory Diseases Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Diagnostic Centers

1.3.4 Ambulatory Surgical Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI in Respiratory Diseases Market Perspective (2020-2031)

2.2 Global AI in Respiratory Diseases Growth Trends by Region

2.2.1 Global AI in Respiratory Diseases Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 AI in Respiratory Diseases Historic Market Size by Region (2020-2025)

2.2.3 AI in Respiratory Diseases Forecasted Market Size by Region (2026-2031)

2.3 AI in Respiratory Diseases Market Dynamics

2.3.1 AI in Respiratory Diseases Industry Trends

2.3.2 AI in Respiratory Diseases Market Drivers

2.3.3 AI in Respiratory Diseases Market Challenges

2.3.4 AI in Respiratory Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI in Respiratory Diseases Players by Revenue

3.1.1 Global Top AI in Respiratory Diseases Players by Revenue (2020-2025)

3.1.2 Global AI in Respiratory Diseases Revenue Market Share by Players (2020-2025)

3.2 Global AI in Respiratory Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by AI in Respiratory Diseases Revenue

3.4 Global AI in Respiratory Diseases Market Concentration Ratio

3.4.1 Global AI in Respiratory Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI in Respiratory Diseases Revenue in 2024

3.5 Global Key Players of AI in Respiratory Diseases Head office and Area Served

3.6 Global Key Players of AI in Respiratory Diseases, Product and Application

3.7 Global Key Players of AI in Respiratory Diseases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 AI in Respiratory Diseases Breakdown Data by Type

4.1 Global AI in Respiratory Diseases Historic Market Size by Type (2020-2025)

4.2 Global AI in Respiratory Diseases Forecasted Market Size by Type (2026-2031)

5 AI in Respiratory Diseases Breakdown Data by Application

5.1 Global AI in Respiratory Diseases Historic Market Size by Application (2020-2025)

5.2 Global AI in Respiratory Diseases Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America AI in Respiratory Diseases Market Size (2020-2031)

6.2 North America AI in Respiratory Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America AI in Respiratory Diseases Market Size by Country (2020-2025)

6.4 North America AI in Respiratory Diseases Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI in Respiratory Diseases Market Size (2020-2031)

7.2 Europe AI in Respiratory Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe AI in Respiratory Diseases Market Size by Country (2020-2025)

7.4 Europe AI in Respiratory Diseases Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI in Respiratory Diseases Market Size (2020-2031)

8.2 Asia-Pacific AI in Respiratory Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific AI in Respiratory Diseases Market Size by Region (2020-2025)

8.4 Asia-Pacific AI in Respiratory Diseases Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI in Respiratory Diseases Market Size (2020-2031)

9.2 Latin America AI in Respiratory Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America AI in Respiratory Diseases Market Size by Country (2020-2025)

9.4 Latin America AI in Respiratory Diseases Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI in Respiratory Diseases Market Size (2020-2031)

10.2 Middle East & Africa AI in Respiratory Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa AI in Respiratory Diseases Market Size by Country (2020-2025)

10.4 Middle East & Africa AI in Respiratory Diseases Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ArtiQ

11.1.1 ArtiQ Company Details

11.1.2 ArtiQ Business Overview

11.1.3 ArtiQ AI in Respiratory Diseases Introduction

11.1.4 ArtiQ Revenue in AI in Respiratory Diseases Business (2020-2025)

11.1.5 ArtiQ Recent Development

11.2 Philips Healthcare

11.2.1 Philips Healthcare Company Details

11.2.2 Philips Healthcare Business Overview

11.2.3 Philips Healthcare AI in Respiratory Diseases Introduction

11.2.4 Philips Healthcare Revenue in AI in Respiratory Diseases Business (2020-2025)

11.2.5 Philips Healthcare Recent Development

11.3 GE Healthcare

11.3.1 GE Healthcare Company Details

11.3.2 GE Healthcare Business Overview

11.3.3 GE Healthcare AI in Respiratory Diseases Introduction

11.3.4 GE Healthcare Revenue in AI in Respiratory Diseases Business (2020-2025)

11.3.5 GE Healthcare Recent Development

11.4 Siemens Healthineers

11.4.1 Siemens Healthineers Company Details

11.4.2 Siemens Healthineers Business Overview

11.4.3 Siemens Healthineers AI in Respiratory Diseases Introduction

11.4.4 Siemens Healthineers Revenue in AI in Respiratory Diseases Business (2020-2025)

11.4.5 Siemens Healthineers Recent Development

11.5 Swaasa AI

11.5.1 Swaasa AI Company Details

11.5.2 Swaasa AI Business Overview

11.5.3 Swaasa AI AI in Respiratory Diseases Introduction

11.5.4 Swaasa AI Revenue in AI in Respiratory Diseases Business (2020-2025)

11.5.5 Swaasa AI Recent Development

11.6 THIRONA

11.6.1 THIRONA Company Details

11.6.2 THIRONA Business Overview

11.6.3 THIRONA AI in Respiratory Diseases Introduction

11.6.4 THIRONA Revenue in AI in Respiratory Diseases Business (2020-2025)

11.6.5 THIRONA Recent Development

11.7 DeepMind Health

11.7.1 DeepMind Health Company Details

11.7.2 DeepMind Health Business Overview

11.7.3 DeepMind Health AI in Respiratory Diseases Introduction

11.7.4 DeepMind Health Revenue in AI in Respiratory Diseases Business (2020-2025)

11.7.5 DeepMind Health Recent Development

11.8 Verily

11.8.1 Verily Company Details

11.8.2 Verily Business Overview

11.8.3 Verily AI in Respiratory Diseases Introduction

11.8.4 Verily Revenue in AI in Respiratory Diseases Business (2020-2025)

11.8.5 Verily Recent Development

11.9 VIDA Diagnostics Inc

11.9.1 VIDA Diagnostics Inc Company Details

11.9.2 VIDA Diagnostics Inc Business Overview

11.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Introduction

11.9.4 VIDA Diagnostics Inc Revenue in AI in Respiratory Diseases Business (2020-2025)

11.9.5 VIDA Diagnostics Inc Recent Development

11.10 Icometrix

11.10.1 Icometrix Company Details

11.10.2 Icometrix Business Overview

11.10.3 Icometrix AI in Respiratory Diseases Introduction

11.10.4 Icometrix Revenue in AI in Respiratory Diseases Business (2020-2025)

11.10.5 Icometrix Recent Development

11.11 Infervision

11.11.1 Infervision Company Details

11.11.2 Infervision Business Overview

11.11.3 Infervision AI in Respiratory Diseases Introduction

11.11.4 Infervision Revenue in AI in Respiratory Diseases Business (2020-2025)

11.11.5 Infervision Recent Development

11.12 PneumoWave

11.12.1 PneumoWave Company Details

11.12.2 PneumoWave Business Overview

11.12.3 PneumoWave AI in Respiratory Diseases Introduction

11.12.4 PneumoWave Revenue in AI in Respiratory Diseases Business (2020-2025)

11.12.5 PneumoWave Recent Development

11.13 Respiray

11.13.1 Respiray Company Details

11.13.2 Respiray Business Overview

11.13.3 Respiray AI in Respiratory Diseases Introduction

11.13.4 Respiray Revenue in AI in Respiratory Diseases Business (2020-2025)

11.13.5 Respiray Recent Development

11.14 Dectrocel Healthcare

11.14.1 Dectrocel Healthcare Company Details

11.14.2 Dectrocel Healthcare Business Overview

11.14.3 Dectrocel Healthcare AI in Respiratory Diseases Introduction

11.14.4 Dectrocel Healthcare Revenue in AI in Respiratory Diseases Business (2020-2025)

11.14.5 Dectrocel Healthcare Recent Development

11.15 Zynnon

11.15.1 Zynnon Company Details

11.15.2 Zynnon Business Overview

11.15.3 Zynnon AI in Respiratory Diseases Introduction

11.15.4 Zynnon Revenue in AI in Respiratory Diseases Business (2020-2025)

11.15.5 Zynnon Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global AI in Respiratory Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Pulmonary Infection

Table 3. Key Players of MRI

Table 4. Key Players of CT Scan

Table 5. Global AI in Respiratory Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global AI in Respiratory Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global AI in Respiratory Diseases Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global AI in Respiratory Diseases Market Share by Region (2020-2025)

Table 9. Global AI in Respiratory Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global AI in Respiratory Diseases Market Share by Region (2026-2031)

Table 11. AI in Respiratory Diseases Market Trends

Table 12. AI in Respiratory Diseases Market Drivers

Table 13. AI in Respiratory Diseases Market Challenges

Table 14. AI in Respiratory Diseases Market Restraints

Table 15. Global AI in Respiratory Diseases Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global AI in Respiratory Diseases Market Share by Players (2020-2025)

Table 17. Global Top AI in Respiratory Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Respiratory Diseases as of 2024)

Table 18. Ranking of Global Top AI in Respiratory Diseases Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by AI in Respiratory Diseases Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of AI in Respiratory Diseases, Headquarters and Area Served

Table 21. Global Key Players of AI in Respiratory Diseases, Product and Application

Table 22. Global Key Players of AI in Respiratory Diseases, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global AI in Respiratory Diseases Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global AI in Respiratory Diseases Revenue Market Share by Type (2020-2025)

Table 26. Global AI in Respiratory Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global AI in Respiratory Diseases Revenue Market Share by Type (2026-2031)

Table 28. Global AI in Respiratory Diseases Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global AI in Respiratory Diseases Revenue Market Share by Application (2020-2025)

Table 30. Global AI in Respiratory Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global AI in Respiratory Diseases Revenue Market Share by Application (2026-2031)

Table 32. North America AI in Respiratory Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America AI in Respiratory Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America AI in Respiratory Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe AI in Respiratory Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe AI in Respiratory Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe AI in Respiratory Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific AI in Respiratory Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific AI in Respiratory Diseases Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific AI in Respiratory Diseases Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America AI in Respiratory Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America AI in Respiratory Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America AI in Respiratory Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa AI in Respiratory Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa AI in Respiratory Diseases Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa AI in Respiratory Diseases Market Size by Country (2026-2031) & (US$ Million)

Table 47. ArtiQ Company Details

Table 48. ArtiQ Business Overview

Table 49. ArtiQ AI in Respiratory Diseases Product

Table 50. ArtiQ Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 51. ArtiQ Recent Development

Table 52. Philips Healthcare Company Details

Table 53. Philips Healthcare Business Overview

Table 54. Philips Healthcare AI in Respiratory Diseases Product

Table 55. Philips Healthcare Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 56. Philips Healthcare Recent Development

Table 57. GE Healthcare Company Details

Table 58. GE Healthcare Business Overview

Table 59. GE Healthcare AI in Respiratory Diseases Product

Table 60. GE Healthcare Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 61. GE Healthcare Recent Development

Table 62. Siemens Healthineers Company Details

Table 63. Siemens Healthineers Business Overview

Table 64. Siemens Healthineers AI in Respiratory Diseases Product

Table 65. Siemens Healthineers Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 66. Siemens Healthineers Recent Development

Table 67. Swaasa AI Company Details

Table 68. Swaasa AI Business Overview

Table 69. Swaasa AI AI in Respiratory Diseases Product

Table 70. Swaasa AI Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 71. Swaasa AI Recent Development

Table 72. THIRONA Company Details

Table 73. THIRONA Business Overview

Table 74. THIRONA AI in Respiratory Diseases Product

Table 75. THIRONA Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 76. THIRONA Recent Development

Table 77. DeepMind Health Company Details

Table 78. DeepMind Health Business Overview

Table 79. DeepMind Health AI in Respiratory Diseases Product

Table 80. DeepMind Health Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 81. DeepMind Health Recent Development

Table 82. Verily Company Details

Table 83. Verily Business Overview

Table 84. Verily AI in Respiratory Diseases Product

Table 85. Verily Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 86. Verily Recent Development

Table 87. VIDA Diagnostics Inc Company Details

Table 88. VIDA Diagnostics Inc Business Overview

Table 89. VIDA Diagnostics Inc AI in Respiratory Diseases Product

Table 90. VIDA Diagnostics Inc Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 91. VIDA Diagnostics Inc Recent Development

Table 92. Icometrix Company Details

Table 93. Icometrix Business Overview

Table 94. Icometrix AI in Respiratory Diseases Product

Table 95. Icometrix Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 96. Icometrix Recent Development

Table 97. Infervision Company Details

Table 98. Infervision Business Overview

Table 99. Infervision AI in Respiratory Diseases Product

Table 100. Infervision Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 101. Infervision Recent Development

Table 102. PneumoWave Company Details

Table 103. PneumoWave Business Overview

Table 104. PneumoWave AI in Respiratory Diseases Product

Table 105. PneumoWave Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 106. PneumoWave Recent Development

Table 107. Respiray Company Details

Table 108. Respiray Business Overview

Table 109. Respiray AI in Respiratory Diseases Product

Table 110. Respiray Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 111. Respiray Recent Development

Table 112. Dectrocel Healthcare Company Details

Table 113. Dectrocel Healthcare Business Overview

Table 114. Dectrocel Healthcare AI in Respiratory Diseases Product

Table 115. Dectrocel Healthcare Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 116. Dectrocel Healthcare Recent Development

Table 117. Zynnon Company Details

Table 118. Zynnon Business Overview

Table 119. Zynnon AI in Respiratory Diseases Product

Table 120. Zynnon Revenue in AI in Respiratory Diseases Business (2020-2025) & (US$ Million)

Table 121. Zynnon Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. AI in Respiratory Diseases Picture

Figure 2. Global AI in Respiratory Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global AI in Respiratory Diseases Market Share by Type: 2024 VS 2031

Figure 4. Pulmonary Infection Features

Figure 5. MRI Features

Figure 6. CT Scan Features

Figure 7. Global AI in Respiratory Diseases Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global AI in Respiratory Diseases Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Diagnostic Centers Case Studies

Figure 11. Ambulatory Surgical Centers Case Studies

Figure 12. Others Case Studies

Figure 13. AI in Respiratory Diseases Report Years Considered

Figure 14. Global AI in Respiratory Diseases Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global AI in Respiratory Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global AI in Respiratory Diseases Market Share by Region: 2024 VS 2031

Figure 17. Global AI in Respiratory Diseases Market Share by Players in 2024

Figure 18. Global Top AI in Respiratory Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Respiratory Diseases as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by AI in Respiratory Diseases Revenue in 2024

Figure 20. North America AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America AI in Respiratory Diseases Market Share by Country (2020-2031)

Figure 22. United States AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe AI in Respiratory Diseases Market Share by Country (2020-2031)

Figure 26. Germany AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific AI in Respiratory Diseases Market Share by Region (2020-2031)

Figure 34. China AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America AI in Respiratory Diseases Market Share by Country (2020-2031)

Figure 42. Mexico AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa AI in Respiratory Diseases Market Share by Country (2020-2031)

Figure 46. Turkey AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE AI in Respiratory Diseases Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. ArtiQ Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 50. Philips Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 51. GE Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 52. Siemens Healthineers Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 53. Swaasa AI Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 54. THIRONA Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 55. DeepMind Health Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 56. Verily Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 57. VIDA Diagnostics Inc Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 58. Icometrix Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 59. Infervision Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 60. PneumoWave Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 61. Respiray Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 62. Dectrocel Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 63. Zynnon Revenue Growth Rate in AI in Respiratory Diseases Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions